Teligene
Teligene (Suzhou Teligene Biotechnology Co., Ltd.) is a clinical-stage biopharmaceutical company founded in 2011 in Suzhou, China by Dr. Zhang Dawei, a former chief scientist at Amgen. The company focuses on the design, research and industrialization of innovative small-molecule targeted drugs for oncology, with a pipeline addressing lung cancer, breast cancer, and head and neck squamous cell carcinoma. Teligene US LLC is a wholly owned US subsidiary advancing these candidates through clinical development. It was surfaced as a portfolio company of idg-capital and added to the API Evangelist network for enrichment; as a drug-development biotech it publishes no public API, developer portal, or machine-readable API surface.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Teligene is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Teligene scores 5.7/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Resources
Every other property we hold for Teligene — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Company 2
The organization behind the API
Teligene is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/teligene · machine-readable index on apis.io